Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide vs other antidiabetic agents in type 2 diabetes mellitus (Japan, Phase 3)
jRCT2080223119Phase 3Completed
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 3 trial of semaglutide in type 2 diabetes mellitus (T2DM) (2 arms). Started Feb 2016; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080223119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223119.